Differential expression of chemokines in patients with localized and diffuse cutaneous American leishmaniasis

被引:103
作者
Ritter, U
Moll, H
Laskay, T
Brocker, EB
Velazco, O
Becker, I
Gillitzer, R
机构
[1] UNIV WURZBURG,DEPT DERMATOL,D-97080 WURZBURG,GERMANY
[2] UNIV WURZBURG,INFECT DIS RES CTR,D-97080 WURZBURG,GERMANY
[3] UNIV ERLANGEN NURNBERG,INST CLIN MICROBIOL & IMMUNOL,NURNBERG,GERMANY
[4] NATL AUTONOMOUS UNIV MEXICO,NATL INST DIAGNOST & EPIDEMIOL,MEXICO CITY,DF,MEXICO
[5] NATL AUTONOMOUS UNIV MEXICO,DEPT EXPTL MED,MEXICO CITY,DF,MEXICO
关键词
D O I
10.1093/infdis/173.3.699
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The abundance of macrophages in localized cutaneous leishmaniasis (LCL) and diffuse cutaneous leishmaniasis (DCL) lesions and differences in the composition of T cell subsets indicate involvement of cell-specific chemotaxis processes. The expression of macrophage chemoattractant protein (MCP)-1, macrophage inflammatory protein (MIP)-1 alpha and -1 beta, RANTES (regulated on activation, normal T cell expressed and secreted), I-309, and interleukin-8 were investigated in lesions of patients with LCL or DCL. In LCL, high levels of MCP-1 and moderate levels of MIP-1 alpha were detected. In DCL, MCP-1 expression was significantly lower and MIP-1 alpha expression was predominant, All other chemokines investigated were minimally expressed or absent, These findings suggest that MCP-1 and MIP-1 alpha are responsible for the recruitment of macrophages and T cells in cutaneous leishmaniasis. The results show that self-healing LCL is associated with higher levels of MCP-1, which may stimulate macrophage microbicidal mechanisms, and nonhealing DCL is associated with higher levels of MIP-1 alpha.
引用
收藏
页码:699 / 709
页数:11
相关论文
共 41 条
[1]   THE INTERACTION OF LEISHMANIA SPECIES WITH MACROPHAGES [J].
ALEXANDER, J .
ADVANCES IN PARASITOLOGY, 1992, 31 :175-254
[2]  
ANGERER LM, 1987, IN SITU HYBRIDIZATIO, P42
[3]  
[Anonymous], 1989, SYNTHETIC OLIGONUCLE
[4]   CC-CHEMOKINES IN ALLERGIC INFLAMMATION [J].
BAGGIOLINI, M ;
DAHINDEN, CA .
IMMUNOLOGY TODAY, 1994, 15 (03) :127-133
[5]   EVALUATION OF T-CELL SUBSETS IN THE LESION INFILTRATES OF HUMAN CUTANEOUS AND MUCOCUTANEOUS LEISHMANIASIS [J].
BARRAL, A ;
JESUS, AR ;
ALMEIDA, RP ;
CARVALHO, EM ;
BARRALNETTO, M ;
COSTA, JML ;
BADARO, R ;
ROCHA, H ;
JOHNSON, WD .
PARASITE IMMUNOLOGY, 1987, 9 (04) :487-497
[6]   PARASITISM OF EPIDERMAL LANGERHANS CELLS IN EXPERIMENTAL CUTANEOUS LEISHMANIASIS WITH LEISHMANIA-MAJOR [J].
BLANK, C ;
FUCHS, H ;
RAPPERSBERGER, K ;
ROLLINGHOFF, M ;
MOLL, H .
JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (02) :418-425
[7]  
CACERESDITTMAR G, 1993, CLIN EXP IMMUNOL, V91, P500, DOI 10.1111/j.1365-2249.1993.tb05931.x
[8]   MONOCYTE CHEMOATTRACTANT PROTEIN-1 ACTS AS A T-LYMPHOCYTE CHEMOATTRACTANT [J].
CARR, MW ;
ROTH, SJ ;
LUTHER, E ;
ROSE, SS ;
SPRINGER, TA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) :3652-3656
[9]   PRODUCTION OF THE RANTES CHEMOKINE IN DELAYED-TYPE HYPERSENSITIVITY REACTIONS - INVOLVEMENT OF MACROPHAGES AND ENDOTHELIAL-CELLS [J].
DEVERGNE, O ;
MARFAINGKOKA, A ;
SCHALL, TT ;
LEGERRAVET, MB ;
SADICK, M ;
PEUCHMAUR, M ;
CREVON, MC ;
KIM, T ;
GALANAUD, P ;
EMILIE, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (05) :1689-1694
[10]  
FAHEY TJ, 1992, J IMMUNOL, V148, P2764